Moore Capital Management »

Axsome Therapeutics shares owned by Moore Capital Management

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Moore Capital Management from 13F filings

Historical chart of Moore Capital Management investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Moore Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Moore Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $685k 9.8k 69.89
2023-06-30 $1.1M 15k 71.86

More positions owned by Moore Capital Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Meta Platforms Cl A Call Option (META)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Bank of America Corporation (BAC)
Amazon (AMZN)
Freeport-mcmoran CL B Call Option (FCX)
Ally Financial (ALLY)
Aon Shs Cl A (AON)
Spotify Technology S A SHS (SPOT)
Netflix (NFLX)

View all positions for Moore Capital Management

Top funds holding Axsome Therapeutics

Vanguard Group
BlackRock
Wellington Management Company
Rtw Investments
Macquarie Group
Geode Capital Management
Invesco
State Street Corporation
FMR
Deep Track Capital
Fairmount Funds Management
Eventide Asset Management
Alethea Capital Management
Susquehanna International
OrbiMed Advisors

View all funds holding Axsome Therapeutics